FOR SALE

Quote






This is starting to look more interesting given what’s going on in Europe. So many people are becoming bullish on healthcare. Merger & acquisition frenzy is just beginning, a lot of people are saying that so many of the small caps are going to get gobbled up for the next 12 to 24 months. There’s a high premium placed on profitability, approved products and total addressable market. ESPR check all the boxes.
 






You forgot to flush after that post! This is a penny stock! Get it through your head. All the Scientific Hires and worthless management Moro s have absolutely no idea what their doing. You should feel embarrassed to be out in the field with this boileroom operation. Insurance isn't covering this!!
 






anonymous said:
You forgot to flush after that post! This is a penny stock! Get it through your head. All the Scientific Hires and worthless management Moro s have absolutely no idea what their doing. You should feel embarrassed to be out in the field with this boileroom operation. Insurance isn't covering this!!
Click to expand...
Oh, Karen. You’re dumb.
 






Karen raises some fair objections. Coverage one of her concerns and a valid one continues to get better and better with some major breakthroughs slated to happen in the next 60 days. Yes having good coverage is needed to sell the volume of product that we anticipate given the total addressable market and our current Momentum. This is clearly not the Experion of 2020, this is a company that’s entering a hyper growth stage. so many of us are looking forward to hanging onto the ride here as we catch a big wave and ride it all the way to spectacular payday. I’m not sure, but I don’t think Karen actually got hired, kind of explains the bitterness.
 






anonymous said:
Karen raises some fair objections. Coverage one of her concerns and a valid one continues to get better and better with some major breakthroughs slated to happen in the next 60 days. Yes having good coverage is needed to sell the volume of product that we anticipate given the total addressable market and our current Momentum. This is clearly not the Experion of 2020, this is a company that’s entering a hyper growth stage. so many of us are looking forward to hanging onto the ride here as we catch a big wave and ride it all the way to spectacular payday. I’m not sure, but I don’t think Karen actually got hired, kind of explains the bitterness.
Click to expand...
Oh, okay. Three cheers for Karen!
 






anonymous said:
Karen raises some fair objections. Coverage one of her concerns and a valid one continues to get better and better with some major breakthroughs slated to happen in the next 60 days. Yes having good coverage is needed to sell the volume of product that we anticipate given the total addressable market and our current Momentum. This is clearly not the Experion of 2020, this is a company that’s entering a hyper growth stage. so many of us are looking forward to hanging onto the ride here as we catch a big wave and ride it all the way to spectacular payday. I’m not sure, but I don’t think Karen actually got hired, kind of explains the bitterness.
Click to expand...
Coverage is not the issue. It’s getting covered. The issue is the dilution of stock and high debt, combined with reckless spending. This is a $1-3 stock for a reason. It will remain so, and all your stupid posts aren’t going to change it. It is not being looked at as a valuable buy from either a stock perspective, or a big pharma purchase. Admit it, you guys went too far. This company could be a blockbuster but it’s still not going to be attractive from a business perspective.
 






anonymous said:
Coverage is not the issue. It’s getting covered. The issue is the dilution of stock and high debt, combined with reckless spending. This is a $1-3 stock for a reason. It will remain so, and all your stupid posts aren’t going to change it. It is not being looked at as a valuable buy from either a stock perspective, or a big pharma purchase. Admit it, you guys went too far. This company could be a blockbuster but it’s still not going to be attractive from a business perspective.
Click to expand...
Well, you gotta spend money to make money. The company clearly made a very wise investment and the clinical outcome study, and is now in the process of leveraging these results internationally and in the United States. OK so US is a little bit behind. Back remains with the growth happening in parts of the world, and we are not too far behind in realizing the same. Additionally, the legal department has successfully extended the patent, so again a very wise investment that is paying off. Then you have NASCAR, perhaps one of the most savvy pure plays on creating awareness in a very large and brand loyal marketplace. Who was 6… oh yeah Mark Martin in the VIAGRA car. Your brain is the size of a shriveled up pea, that is more atrophied than Limberger cheese.
 






anonymous said:
Well, you gotta spend money to make money. The company clearly made a very wise investment and the clinical outcome study, and is now in the process of leveraging these results internationally and in the United States. OK so US is a little bit behind. Back remains with the growth happening in parts of the world, and we are not too far behind in realizing the same. Additionally, the legal department has successfully extended the patent, so again a very wise investment that is paying off. Then you have NASCAR, perhaps one of the most savvy pure plays on creating awareness in a very large and brand loyal marketplace. Who was 6… oh yeah Mark Martin in the VIAGRA car. Your brain is the size of a shriveled up pea, that is more atrophied than Limberger cheese.
Click to expand...
Whatever you say buddy
 






So we are going to be replacing the Volvo XC40 with the Volvo XC40 Recharge. Esperion is really doing the right thing for the environment. Rollout is scheduled for earth day!
 






anonymous said:
You forgot to flush after that post! This is a penny stock! Get it through your head. All the Scientific Hires and worthless management Moro s have absolutely no idea what their doing. You should feel embarrassed to be out in the field with this boileroom operation. Insurance isn't covering this!!
Click to expand...

True.

And how many $$$millions is Esperion burning through each month ?
 






anonymous said:
So we are going to be replacing the Volvo XC40 with the Volvo XC40 Recharge. Esperion is really doing the right thing for the environment. Rollout is scheduled for earth day!
Click to expand...


This is a really great idea. Many pharma companies are going with EVs because they reduce pollution and greenhouse gases. They will also save lots of money on fuel.
 






anonymous said:
This is a really great idea. Many pharma companies are going with EVs because they reduce pollution and greenhouse gases. They will also save lots of money on fuel.
Click to expand...
And maintenance too. Doing right is doing good, just like Bempedoic acid for patients at risk. So many positives are into focus now, there is more good news soon to come with many major payers now about to get on board in the quest to reduce the burden and toll of CVD. Good times!
 


















anonymous said:
Karen raises some fair objections. Coverage one of her concerns and a valid one continues to get better and better with some major breakthroughs slated to happen in the next 60 days. Yes having good coverage is needed to sell the volume of product that we anticipate given the total addressable market and our current Momentum. This is clearly not the Experion of 2020, this is a company that’s entering a hyper growth stage. so many of us are looking forward to hanging onto the ride here as we catch a big wave and ride it all the way to spectacular payday. I’m not sure, but I don’t think Karen actually got hired, kind of explains the bitterness.
Click to expand...

Get lost Anthony. Your Dream Team Scientificall Hired and now Lipid Experts are the joke of the industry.
 






anonymous said:
Well, you gotta spend money to make money. The company clearly made a very wise investment and the clinical outcome study, and is now in the process of leveraging these results internationally and in the United States. OK so US is a little bit behind. Back remains with the growth happening in parts of the world, and we are not too far behind in realizing the same. Additionally, the legal department has successfully extended the patent, so again a very wise investment that is paying off. Then you have NASCAR, perhaps one of the most savvy pure plays on creating awareness in a very large and brand loyal marketplace. Who was 6… oh yeah Mark Martin in the VIAGRA car. Your brain is the size of a shriveled up pea, that is more atrophied than Limberger cheese.
Click to expand...

Your LDL patie is don't give a crap about NASCAR. What a buffoon move Sheldon. Esperions money burn continues.
 












We’re starting to see a lot more inside action and obviously this bodes well. These are the folks that know the most, and they are putting a stake in the ground around the possibilities for the future. So many people are becoming engaged and have their eyes on the prize. It’s not about small moves up or down in any one day or week, this is a long-term investment that will likely reward those who are patient, and also patients in general. CHD is still the number one cause of death; we are poised to make a dent in the human toll taken from this “silent killer”. we should all be proud to see the company engaging in activities to raise awareness and have a positive social impact through events like NASCAR.
 












Top Bottom
Back
Quote